Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes (Sept 2016).

Written By Kate

Download: https://pubmed.ncbi.nlm.nih.gov/27599330/

Journal: JAMA

“Gadolinium MRI at any time during pregnancy was associated with an increased risk of a broad set of rheumatological, inflammatory, or infiltrative skin conditions and for stillbirth or neonatal death.”

Authors: Joel G Ray 1, Marian J Vermeulen 2, Aditya Bharatha 3, Walter J Montanera 3, Alison L Park 4

  • 1Departments of Medicine, and Obstetrics and Gynecology, St Michael's Hospital, Toronto, Ontario, Canada2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3University of Toronto, Toronto, Ontario, Canada5Keenan Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.

  • 2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3University of Toronto, Toronto, Ontario, Canada.

  • 3University of Toronto, Toronto, Ontario, Canada4Department of Medical Imaging, St Michael's Hospital, Toronto, Ontario, Canada.

  • 4Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada5Keenan Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.

Kate
Previous

“Gadolinium Speciation” Presentation

Next

Gadolinium toxicity: Iron and ferroportin as central targets (2016).